Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
A purified anthraquinone-glycoside preparation from rhubarb ameliorates type 2 diabetes mellitus by modulating the gut microbiota and reducing inflammation
Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer
SGLT2 inhibition: a new era in renoprotective medicine
Mental and cognitive functions naturally decline with age, which can increase the risk of neurodegenerative disorders like dementia
Int J Vitam Nutr Res 2001, 71: 82-86